tiprankstipranks
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
US Market
CTMX
CytomX Therapeutics
RESEARCH TOOLSreports
Want to see CTMX full AI Analyst Report?

CytomX Therapeutics (CTMX) Income Statement

953 Followers

CytomX Therapeutics Income Statement

Last quarter (Q4 2025), CytomX Therapeutics's total revenue was $663.00K, a decrease of -98.26% from the same quarter last year. In Q4, CytomX Therapeutics's net income was $-26.51M. See CytomX Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 76.20M$ 138.10M$ 101.21M$ 53.16M$ 37.31M
Gross Profit
$ 76.20M$ 138.10M$ 101.21M$ 53.16M$ 37.31M
Operating Expenses
$ 95.77M$ 113.11M$ 107.70M$ 154.50M$ 153.35M
Depreciation and Amortization
$ 1.38M$ 1.77M$ 2.17M$ 2.44M$ 2.71M
EBITDA
$ -18.19M$ 26.76M$ -4.31M$ -98.89M$ -113.34M
Operating Income
$ -19.56M$ 25.00M$ -6.48M$ -101.33M$ -116.04M
Other Income/Expenses
$ 2.43M$ 7.10M$ 9.81M$ 2.02M$ 172.00K
Pretax Income
$ -17.13M$ 32.09M$ 3.32M$ -99.32M$ -115.87M
Net Income
$ -17.37M$ 31.87M$ -569.00K$ -99.32M$ -115.87M
Per Share Metrics
Basic EPS
$ -0.15$ 0.38$ -0.01$ -1.48$ -1.26
Diluted EPS
$ -0.15$ 0.38$ -0.01$ -1.48$ -1.26
Weighted Average Shares Outstanding
 137.94M 84.44M 73.81M 65.74M 64.15M
Weighted Average Shares Outstanding (Diluted)
 137.94M 84.75M 73.81M 65.74M 64.15M
Currency in USD

CytomX Therapeutics Earnings and Revenue History